FEMAMED 2.5 (Letrozole) belongs to a gaggle of medicines called aromatase inhibitors. it's a hormonal (or “endocrine”) carcinoma treatment. The growth of carcinoma is usually stimulated by estrogens which are female sex hormones.
FEMAMED 2.5 reduces the quantity of estrogen by blocking an enzyme (“aromatase”) involved within the production of estrogens and thus may block the expansion of carcinoma that needs estrogens to grow.
Ship to (USD)
